Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 7

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Laponite®-Based Smart Hydrogels for Sustained Topical Delivery of Silver Sulfadiazine: A Strategy for the Treatment of Contaminated or Biofilm-Forming Wounds

do Nascimento, Jonas Lira, da Costa, Michely Conceição Viana, de Macêdo, Leticia Farias, de Macêdo, Luiz Henrique Chaves, de Moura, Ricardo Olímpio, de Mélo, Tomás Jeferson Alves, da Rocha, Wilma Raianny Vieira, de Melo Costa, Ana Cristina Figueiredo, Soares-Sobrinho, José Lamartine, Silva, Dayanne Tomaz Casimiro da · 2025 · Pharmaceutics

Abstract

Background/Objectives: Silver sulfadiazine (AgSD) is widely used in the topical treatment of burns and infected wounds, but its conventional formulations present drawbacks such as poor water solubility, the need for multiple daily applications, and patient discomfort. To overcome these limitations, this study aimed to develop and evaluate Laponite® (LAP)-based hydrogels loaded with AgSD for controlled release and enhanced antimicrobial and antibiofilm efficacy, offering a promising alternative for the treatment of contaminated or biofilm-forming wounds. Methods: Laponite®-based hydrogels containing 1% and 1.2% AgSD (LAP@AgSD) were prepared using a one-pot method. The formulations were characterized rheologically, thermally, and structurally. In vitro drug release was assessed using Franz diffusion cells, and mathematical modeling was applied to determine release kinetics. Antibacterial and antibiofilm activities were evaluated against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa using standardized microbiological methods. Results: LAP@AgSD hydrogels exhibited pseudoplastic behavior, high structural integrity, and enhanced thermal stability. In vitro release assays revealed a sustained release profile, best fitted by the Weibull model, indicating diffusion-controlled mechanisms. Antibacterial assays demonstrated concentration-dependent activity, with LAP@AgSD 1.2% showing superior efficacy over LAP@AgSD 1% and comparable performance to the commercial silver sulfadiazine cream (CC-AgSD). Biofilm inhibition was significant for all formulations, with CC-AgSD 1% exhibiting the highest immediate activity, while LAP@AgSD 1.2% provided sustained antibiofilm potential. Conclusions: LAP-based hydrogels are promising smart delivery systems for AgSD, combining mechanical robustness, controlled drug release, and effective antibacterial and antibiofilm activities. These findings support their potential use in topical therapies for infected and chronic wounds, particularly where biofilm formation is a challenge.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pharmaceutics17091234

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 65

  1. Yakupu, A., Aimaier, R., Yuan, B., Chen, B., Cheng, J., Zhao, Y., Peng, Y., Dong, J., and Lu, S. (2023). The Burden of Skin and Subcutaneous Diseases: Findings from the Global Burden of Disease Study 2019. Front. Public Health, 11. · DOI
  2. Cavallo, I., Sivori, F., Mastrofrancesco, A., Abril, E., Pontone, M., Di Domenico, E.G., and Pimpinelli, F. (2024). Bacterial Biofilm in Chronic Wounds and Possible Therapeutic Approaches. Biology, 13. · DOI · Paper page
  3. Delir, 2020, Clindamycin Releasing Bionanocomposite Hydrogels as Potential Wound Dressings for the Treatment of Infected Wounds, J. Biomater. Sci. Polym. Ed., 31, 1489, 10.1080/09205063.2020.1764161 · doi:10.1080/09205063.2020.1764161
  4. Lowe, 2001, Therapeutic Ultrasound and Wound Closure: Lack of Healing Effect on x-Ray Irradiated Wounds in Murine Skin, Arch. Phys. Med. Rehabil., 82, 1507, 10.1053/apmr.2001.25083 · doi:10.1053/apmr.2001.25083
  5. Federman, 2024, Wound Healing Society 2023 Update on Guidelines for Arterial Ulcers, Wound Repair Regen., 32, 619, 10.1111/wrr.13204 · doi:10.1111/wrr.13204
  6. Guedes, 2023, Physicochemical Characterization of Silver Sulfadiazine in Polymeric Wound Dressings, Curr. Pharm. Des., 29, 865, 10.2174/1381612829666230324122925 · DOI
  7. Abo El-Enin, H.A., Ali, I.H., Naguib, I.A., Tolba, N.S., and Abdel-Bar, H.M. (2025). Augmented Silver Sulfadiazine Nanostructured Lipid Carriers Impregnated Collagen Sponge for Promoting Burn Wound Healing. Int. J. Biol. Macromol., 298. · DOI
  8. Fatima, Q.U.A., Ahmed, N., Siddiqui, B., Rehman, A., ul Haq, I., Khan, G.M., and Elaissari, A. (2022). Enhanced Antimicrobial Activity of Silver Sulfadiazine Cosmetotherapeutic Nanolotion for Burn Infections. Cosmetics, 9. · doi:10.3390/cosmetics9050093
  9. Munhoz, 2019, Alginate Films Functionalized with Silver Sulfadiazine-Loaded [Mg-Al] Layered Double Hydroxide as Antimicrobial Wound Dressing, Int. J. Biol. Macromol., 141, 504, 10.1016/j.ijbiomac.2019.09.019 · doi:10.1016/j.ijbiomac.2019.09.019
  10. He, 2022, Double Crosslinked Polyvinyl Alcohol/Gelatin/Silver Sulfadiazine Sponges with Excellent Antibacterial Performance, Colloids Surf. A Physicochem. Eng. Asp., 643, 128737, 10.1016/j.colsurfa.2022.128737 · DOI
  11. Tort, 2022, A New Insight to Silver Sulfadiazine Antibacterial Dressings: Nanoparticle-Loaded Nanofibers for Controlled Drug Delivery, AAPS PharmSciTech, 24, 8, 10.1208/s12249-022-02465-9 · DOI
  12. Cech, 2016, Efficacy of a New Multifunctional Surfactant-Based Biomaterial Dressing with 1% Silver Sulphadiazine in Chronic Wounds, Int. Wound J., 13, 738, 10.1111/iwj.12361 · DOI
  13. Soltani, 2022, Improved Antibacterial Activity by Incorporation of Silver Sulfadiazine on Nanoporous Cu-BTC Metal-Organic-Framework, Inorganica Chim. Acta, 543, 121182, 10.1016/j.ica.2022.121182 · doi:10.1016/j.ica.2022.121182
  14. Samoylenko, 2022, Biomedical Applications of Laponite®-Based Nanomaterials and Formulations, Springer Proc. Phys., 266, 385, 10.1007/978-3-030-80924-9_15 · DOI
  15. Alves, 2017, Laponite®: A Key Nanoplatform for Biomedical Applications?, Nanomedicine, 17, 30091
  16. Suterio, 2022, Laponite® Gel Formulation Containing Simvastatin for Melanoma Treatment, Appl. Clay Sci., 228, 106651, 10.1016/j.clay.2022.106651 · doi:10.1016/j.clay.2022.106651
  17. Munoz-Perez, E., Perez-Valle, A., Igartua, M., Santos-Vizcaino, E., and Hernandez, R.M. (2023). High Resolution and Fidelity 3D Printing of Laponite and Alginate Ink Hydrogels for Tunable Biomedical Applications. Biomater. Adv., 149. · DOI
  18. 2017, Laponite as a Rheology Modifier of Alginate Solutions: Physical Gelation and Aging Evolution, Carbohydr. Polym., 157, 1, 10.1016/j.carbpol.2016.09.057 · DOI
  19. Mahkam, 2016, Preparation of New PH-Sensitive Nanocomposites through in Situ Copolymerization of Methacrylic Acid with Ionic Liquid-Modified Laponite Clay, Polym. Plast. Technol. Eng., 55, 1604, 10.1080/03602559.2016.1163596 · DOI
  20. Ghadiri, 2014, Antibiotic Eluting Clay Mineral (Laponite®) for Wound Healing Application: An in Vitro Study, J. Mater. Sci. Mater. Med., 25, 2513, 10.1007/s10856-014-5272-7 · doi:10.1007/s10856-014-5272-7
  21. Pacelli, 2016, Gellan Gum Methacrylate and Laponite as an Innovative Nanocomposite Hydrogel for Biomedical Applications, Eur. Polym. J., 77, 114, 10.1016/j.eurpolymj.2016.02.007 · DOI
  22. Zhou, 2024, Laponite/Lactoferrin Hydrogel Loaded with Eugenol for Methicillin-Resistant Staphylococcus Aureus-Infected Chronic Skin Wound Healing, J. Tissue Viability, 33, 487, 10.1016/j.jtv.2024.05.006 · DOI · Paper page
  23. Chen, 2022, Thixotropy research of laponite-hydrogel composites for water shutoff in horizontal wells, J. Pet. Sci. Eng., 208, 109600, 10.1016/j.petrol.2021.109600 · doi:10.1016/j.petrol.2021.109600
  24. Long, 2025, Novel Preparation of Laponite Based Theranostic Silver Nanocomposite for Drug Delivery, Radical Scavenging and Healing Efficiency for Wound Care Management after Surgery, Regen. Ther., 28, 235, 10.1016/j.reth.2024.12.004 · doi:10.1016/j.reth.2024.12.004
  25. Hu, Y., Xu, W., Sun, L., Ma, X., Zhou, P., Zhang, C., Cai, R., Wang, X., Yang, H., and Tao, G. (2025). Multifunctional Injectable Hydrogel Incorporating EGCG-Cu Complexes for Synergistic Antibacterial, Immunomodulatory, and Osteogenic Therapy in Periodontitis. Mater. Today Bio, 32. · DOI
  26. Qu, 2021, Self-Assembled Caseinate-Laponite® Nanocomposites for Curcumin Delivery, Food Chem., 363, 130338, 10.1016/j.foodchem.2021.130338 · DOI
  27. Ferreira, 2023, Absorption of Essential Oils in Laponite: Stability Enhancement and Structural Characteristics, Appl. Clay Sci., 238, 106936, 10.1016/j.clay.2023.106936 · doi:10.1016/j.clay.2023.106936
  28. Imbriano, 2025, Development of Nanoemulgel System Based on Opuntia Ficus-Indica (L.) Seed Oil and Nanoclays: Formulation, Characterization and Application for Wound Treatment, J. Drug Deliv. Sci. Technol., 111, 107151, 10.1016/j.jddst.2025.107151 · doi:10.1016/j.jddst.2025.107151
  29. Brunchi, C.-E., and Morariu, S. (2024). Laponite®—From Dispersion to Gel—Structure, Properties, and Applications. Molecules, 29. · doi:10.3390/molecules29122823
  30. 2023, Weibull β Value for the Discernment of Drug Release Mechanism of PLGA Particles, Int. J. Pharm., 640, 123017, 10.1016/j.ijpharm.2023.123017 · DOI
  31. Siepmann, 2012, Modeling of Diffusion Controlled Drug Delivery, J. Control. Release, 161, 351, 10.1016/j.jconrel.2011.10.006 · DOI · Paper page
  32. Moreira, V.M., Leite, J.M.D.S., Medeiros, K.D.A., de Assis, K.M.A., Borges, J.C., Santana, L.M.B., Moreira, L.M.C.d.C., Alves, L.P., de Oliveira, T.K.B., and de Souza da Silveira, J.W. (2023). Pentoxifylline/Chitosan Films on Wound Healing: In Vitro/In Vivo Evaluation. Pharmaceutics, 15. · DOI
  33. Ritger, 1987, A Simple Equation for Description of Solute Release I. Fickian and Non-Fickian Release from Non-Swellable Devices in the Form of Slabs, Spheres, Cylinders or Discs, J. Control. Release, 5, 23, 10.1016/0168-3659(87)90034-4 · DOI · Paper page
  34. Noves, 1897, The Rate of Solution of Solid Substances in Their Onw Solutions, J. Am. Chem. Soc., 19, 930, 10.1021/ja02086a003 · DOI · Paper page
  35. Korsmeyer, 1983, Mechanisms of Solute Release from Porous Hydrophilic Polymers, Int. J. Pharm., 15, 25, 10.1016/0378-5173(83)90064-9 · DOI · Paper page
  36. Peppas, 1989, A Simple Equation for the Description of Solute Release. III. Coupling of Diffusion and Relaxation, Int. J. Pharm., 57, 169, 10.1016/0378-5173(89)90306-2 · DOI · Paper page
  37. Bloor, 1972, Effects of Solubilization on Drug Diffusion, J. Pharm. Pharmacol., 24, 927, 10.1111/j.2042-7158.1972.tb08922.x · doi:10.1111/j.2042-7158.1972.tb08922.x
  38. De Oliveira, G.D., da Rocha, W.R.V., Rodrigues, J.F.B., and Alves, H.D.S. (2023). Synergistic and Antibiofilm Effects of the Essential Oil from Croton Conduplicatus (Euphorbiaceae) against Methicillin-Resistant Staphylococcus Aureus. Pharmaceuticals, 16. · DOI
  39. Munusamy, 2018, A Study on Candida Biofilm Growth Characteristics and Its Susceptibility to Aureobasidin A, Rev. Iberoam. Micol., 35, 68, 10.1016/j.riam.2017.07.001 · DOI
  40. Ruzicka, 2011, A Fresh Look at the Laponite Phase Diagram, Soft Matter, 7, 1268, 10.1039/c0sm00590h · DOI · Paper page
  41. Labanda, 2008, Effect of Aging Time on the Rheology of Laponite Dispersions, Colloids Surf. A Physicochem. Eng. Asp., 329, 1, 10.1016/j.colsurfa.2008.06.035 · doi:10.1016/j.colsurfa.2008.06.035
  42. Bujok, 2022, Insight into the Aqueous Laponite® Nanodispersions for Self-Assembled Poly(Itaconic Acid) Nanocomposite Hydrogels: The Effect of Multivalent Phosphate Dispersants, J. Colloid. Interface Sci., 610, 1, 10.1016/j.jcis.2021.12.055 · doi:10.1016/j.jcis.2021.12.055
  43. Ramli, 2022, Basic Principle and Good Practices of Rheology for Polymers for Teachers and Beginners, Chem. Teach. Int., 4, 307, 10.1515/cti-2022-0010 · DOI · Paper page
  44. Stojkov, 2021, Relationship between Structure and Rheology of Hydrogels for Various Applications, Gels, 7, 255, 10.3390/gels7040255 · DOI · Paper page
  45. Calienni, M.N., Martínez, L.M., Izquierdo, M.C., Alonso, S.D.V., and Montanari, J. (2023). Rheological and Viscoelastic Analysis of Hybrid Formulations for Topical Application. Pharmaceutics, 15. · DOI
  46. Vincová, A., Šantová, K., Kůrová, V., Kratochvílová, A., Halámková, V., Suchánková, M., Lorencová, E., Sumczynski, D., and Salek, R.N. (2023). The Impact of Divergent Algal Hydrocolloids Addition on the Physicochemical, Viscoelastic, Textural, and Organoleptic Properties of Cream Cheese Products. Foods, 12. · DOI
  47. Ibarra, 2020, Sulfadiazine Hosted in MIL-53(Al) as a Biocide Topical Delivery System, RSC Adv., 10, 25645, 10.1039/D0RA03636F · DOI
  48. Yassue-Cordeiro, P.H., Zandonai, C.H., Genesi, B.P., Lopes, P.S., Sanchez-Lopez, E., Garcia, M.L., Fernandes-Machado, N.R.C., Severino, P., Souto, E.B., and da Silva, C.F. (2019). Development of Chitosan/Silver Sulfadiazine/Zeolite Composite Films for Wound Dressing. Pharmaceutics, 11. · DOI
  49. Singh, 2022, Silver Sulfadiazine Loaded Core-Shell Airbrushed Nanofibers for Burn Wound Healing Application, Int. J. Pharm., 613, 121358, 10.1016/j.ijpharm.2021.121358 · DOI
  50. Chouhan, 2020, Silk Biomaterials in Wound Healing and Skin Regeneration Therapeutics: From Bench to Bedside, Acta Biomater., 103, 24, 10.1016/j.actbio.2019.11.050 · DOI · Paper page
  51. Magalhães, L.S.S.M., Andrade, D.B., Bezerra, R.D.S., Morais, A.I.S., Oliveira, F.C., Rizzo, M.S., Silva-Filho, E.C., and Lobo, A.O. (2022). Nanocomposite Hydrogel Produced from PEGDA and Laponite for Bone Regeneration. J. Funct. Biomater., 13. · doi:10.3390/jfb13020053
  52. Meena, 2025, Zingerone Nanoparticle and Laponite–Embedded Natural Gum Based Injectable Hydrogel for Fast Track Wound Repair, Colloids Surf. A Physicochem. Eng. Asp., 724, 724, 10.1016/j.colsurfa.2025.137349 · doi:10.1016/j.colsurfa.2025.137349
  53. Kaya, 2020, Spectral Changes in Si–O–Si Stretching Band of Porous Glass Network upon Ingress of Water, J. Non-Cryst. Solids, 527, 119722, 10.1016/j.jnoncrysol.2019.119722 · DOI
  54. Corbi, 2023, Beyond Silver Sulfadiazine: A Dive into More than 50 Years of Research and Development on Metal Complexes of Sulfonamides in Medicinal Inorganic Chemistry, Coord. Chem. Rev., 490, 215228, 10.1016/j.ccr.2023.215228 · DOI
  55. Adepu, S., and Ramakrishna, S. (2021). Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules, 26. · DOI · Paper page
  56. Ojha, 2023, Hydrogels as Potential Controlled Drug Delivery System: Drug Release Mechanism and Applications, Nanosci. Nanotechnol. Asia, 13, 42
  57. Kiaee, 2022, Laponite-Based Nanomaterials for Drug Delivery, Adv. Healthc. Mater., 11, e2102054, 10.1002/adhm.202102054 · DOI · Paper page
  58. Casault, 2008, Systematic Characterization of Drug Release Profiles from Finite-Sized Hydrogels, Phys. A Stat. Mech. Its Appl., 387, 5387, 10.1016/j.physa.2008.05.013 · DOI
  59. Stealey, S.T., Gaharwar, A.K., and Zustiak, S.P. (2023). Laponite-Based Nanocomposite Hydrogels for Drug Delivery Applications. Pharmaceuticals, 16. · DOI
  60. Alberts, A., Moldoveanu, E.T., Niculescu, A.G., and Grumezescu, A.M. (2025). Hydrogels for Wound Dressings: Applications in Burn Treatment and Chronic Wound Care. J. Compos. Sci., 9. · DOI
  61. Khina, 2021, Similarities and Differences in the Mechanism of Antibacterial Action of Silver Ions and Nanoparticles, Appl. Biochem. Microbiol., 57, 683, 10.1134/S0003683821060053 · DOI
  62. Godoy-Gallardo, M., Eckhard, U., Delgado, L.M., de Roo Puente, Y.J.D., Hoyos-Nogués, M., Gil, F.J., and Perez, R.A. (2021). Antibacterial Approaches in Tissue Engineering Using Metal Ions and Nanoparticles: From Mechanisms to Applications. Bioact. Mater., 6. · DOI · Paper page
  63. Flemming, 2025, Microbial Extracellular Polymeric Substances in the Environment, Technology and Medicine, Nat. Rev. Microbiol., 23, 87, 10.1038/s41579-024-01098-y · DOI · Paper page
  64. Guo, 2019, Silver Nanoparticles Exert Concentration-Dependent Influences on Biofilm Development and Architecture, Cell Prolif., 52, e12616, 10.1111/cpr.12616 · DOI
  65. Ghanaim, 2025, Production and Characterization of Exopolysaccharides from Pseudomonas Aeruginosa AG01 with Some Medical Potential Applications, Microb. Cell Fact., 24, 107, 10.1186/s12934-025-02730-z · DOI

Cited by

See all 7

Metadata

Authors
do Nascimento, J. L., da Costa, M. C. V., de Macêdo, L. F., de Macêdo, L. H. C., de Moura, R. O., de Mélo, T. J. A., da Rocha, W. R. V., de Melo Costa, A. C. F., Soares-Sobrinho, J. L., & Silva, D. T. C. D.
Venue
Pharmaceutics
Publisher
MDPI AG
Published
2025-09-22
Volume
17
Issue
9
Pages
1234
ISSN
1999-4923
Cited by
7
References
1
Language
en
Funders
  • Paraiba State University (#01/2025, 382074/2025-4)
  • National Council for Scientific and Technological Development (CNPq) (#01/2025, 382074/2025-4)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Laponite®-Based Smart Hydrogels for Sustained Topical Delivery of Silver Sulfadiazine: A Strategy for the Treatment of Contaminated or Biofilm-Forming Wounds. https://app.cochat.ai/papers/10.3390/pharmaceutics17091234
The paper
do Nascimento, J. L., da Costa, M. C. V., de Macêdo, L. F., de Macêdo, L. H. C., de Moura, R. O., de Mélo, T. J. A., da Rocha, W. R. V., de Melo Costa, A. C. F., Soares-Sobrinho, J. L., & Silva, D. T. C. D. (2025). Laponite®-Based Smart Hydrogels for Sustained Topical Delivery of Silver Sulfadiazine: A Strategy for the Treatment of Contaminated or Biofilm-Forming Wounds. Pharmaceutics. https://doi.org/10.3390/pharmaceutics17091234

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.